DrugPatentWatch Database Preview
Mechanism of Action: Vesicular Monoamine Transporter 2 Inhibitors
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Drugs with Mechanism of Action: Vesicular Monoamine Transporter 2 Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms North | XENAZINE | tetrabenazine | TABLET;ORAL | 021894-001 | Aug 15, 2008 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Valeant Pharms North | XENAZINE | tetrabenazine | TABLET;ORAL | 021894-002 | Aug 15, 2008 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Hetero Labs Ltd V | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 204574-001 | Feb 3, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hetero Labs Ltd V | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 204574-002 | Feb 3, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lupin Ltd | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 210544-001 | Apr 20, 2018 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Mylan | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 207682-001 | Jan 31, 2017 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 207682-002 | Jan 31, 2017 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
